|
TBC1D5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.431900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.401900E-02 |
| Normal-vs-Stage2 |
5.231800E-01 |
| Normal-vs-Stage3 |
9.115800E-01 |
| Normal-vs-Stage4 |
9.99560000000121E-05 |
| Stage1-vs-Stage2 |
7.460800E-01 |
| Stage1-vs-Stage3 |
5.296800E-01 |
| Stage1-vs-Stage4 |
4.5354000000053E-06 |
| Stage2-vs-Stage3 |
7.578600E-01 |
| Stage2-vs-Stage4 |
8.359900E-03 |
| Stage3-vs-Stage4 |
7.345700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.118800E-03 |
| Normal-vs-AfricanAmerican |
9.095400E-01 |
| Normal-vs-Asian |
2.090600E-01 |
| Caucasian-vs-AfricanAmerican |
5.872300E-02 |
| Caucasian-vs-Asian |
1.302010E-01 |
| AfricanAmerican-vs-Asian |
1.795990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.895600E-02 |
| Normal-vs-Female |
5.761600E-02 |
| Male-vs-Female |
6.097600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.616800E-01 |
| Normal-vs-Extreme_Weight |
2.867400E-01 |
| Normal-vs-Obese |
2.803800E-02 |
| Normal-vs-Extreme_Obese |
7.041200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.964800E-01 |
| Normal_Weight-vs-Obese |
3.422400E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.253200E-01 |
| Extreme_Weight-vs-Obese |
4.188800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.821800E-01 |
| Obese-vs-Extreme_Obese |
5.154400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.263000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.536050E-02 |
| Normal-vs-Age(61-80Yrs) |
2.143200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.989200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.391000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.420600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.011000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.558000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.206200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.701000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.031390E-04 |
| Normal-VS-Type2 PRCC |
1.689970E-01 |
| Normal-VS-KIRP CIMP |
2.131600E-01 |
| Normal-VS-Unclassified PRCC |
5.490000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.86119999999934E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.499400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.561400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.894400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.374490E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.482300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.583620E-01 |
| Normal-vs-N1 |
4.976000E-01 |
| Normal-vs-N2 |
3.512000E-02 |
| N0-vs-N1 |
7.928400E-01 |
| N0-vs-N2 |
5.707400E-01 |
| N1-vs-N2 |
5.321600E-01 |
|
|
